Navigation Links
Abstract Submissions and Registration Now Open for 2nd International Symposium on MR-Guided Focused Ultrasound
Date:5/28/2010

CHARLOTTESVILLE, Va., May 28 /PRNewswire-USNewswire/ -- The Focused Ultrasound Surgery Foundation has announced that abstract submissions and registration are now open for the 2nd International Symposium on MR-guided Focused Ultrasound and can be accessed online at www.fusfoundation.org/symposium.

Scheduled for October 17-20, 2010 at the Westfields Marriott near Dulles International Airport, Washington, DC, the symposium will be a premier event for scientists, clinicians and others interested in current and future applications of MR-guided focused ultrasound. The program will offer a multifaceted exploration of this emerging field and feature plenary sessions, panel discussions, poster presentations and technical exhibits.

Abstract submissions

The Foundation welcomes abstracts related to preclinical, translational or clinical research that involves the use of MR-guided focused ultrasound. Topics of interest include, but are not limited to, emerging treatments for the brain, prostate, breast, liver and uterus and for bone tumors, back and neck pain and targeted drug delivery.

Abstract submissions will be accepted through August 16, 2010 and must be entered online.

Abstracts covering late breaking research will be accepted from September 1 through 15, but will not be listed in the symposium program.

Symposium registration

Symposium registration fees will include meeting materials, breakfast and lunch.

Prior to August 1, the registration fee will be $350. Physicians and scientists in training will receive a $100 discount.  On August 1, the registration fee will increase to $450. The discounted fee for trainees will be $300.

About the Focused Ultrasound Surgery Foundation

Founded in 2006 and based in Charlottesville, Virginia, the Focused Ultrasound Surgery Foundation is dedicated to accelerating research and development of treatments using one of today's most revolutionary and promising medical technologies: non-invasive Magnetic Resonance-Guided Focused Ultrasound (FUS). The Foundation's work is motivated by the belief that FUS treatments could become the ultimate in minimally-invasive surgery, serve as a viable alternative to radiation therapy and offer a new platform for precise drug delivery - applications with the potential to alleviate suffering, save lives and quicken recovery times for millions of patients worldwide.

By promoting communication, collaboration and coordination, the Foundation   has become a vital nexus for researchers, clinicians, manufacturers, philanthropists and other stakeholders in the FUS arena. The Foundation is funding translational and clinical research, providing fellowships for training physicians and scientists, hosting symposia and workshops, maintaining online informational resources and establishing FUS Centers of Excellence. Complete information about the Foundation and its work can be found at http://fusfoundation.org/

This news release was issued on behalf of Newswise(TM).  For more information, visit http://www.newswise.com.


'/>"/>
SOURCE Focused Ultrasound Surgery Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Somanetics Corporation Announces 24 Clinical Abstracts on INVOS System Presented at Annual Pediatric Academic Societies National Conference
2. MedImmune to Present Five Abstracts on RSV at Pediatric Academic Societies Annual Meeting
3. NewCardio Leadership to Present Two Abstracts at ISCE Conference
4. DaVita Abstracts Accepted Into National Kidney Foundations 2009 Spring Symposium
5. DaVita Abstracts Highlight Latest Research Developments at Annual Dialysis Conference
6. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
7. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
8. Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
9. Release of Cytopia Abstract for CYT997 Oral Presentation at American Society of Clinical Oncology
10. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
11. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... , Sept. 19, 2017   ZirMed Inc ., a ... today announced that it has been ranked #1 by its ... Book™ Rankings 2017 User Survey. ZirMed was recognized as ... large hospitals and medical centers over 200 beds and holds ... healthcare technology user survey history. ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 /PRNewswire/ ... ratings for global supply chains, has published the first annual edition of ... performance of more than 20,400 companies evaluated by EcoVadis, based on Scorecard ... and 2016. ... Global CSR Risk & Performance Index ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/13/2017)... ... 2017 , ... “America On The Brink”: the Christian history of the United ... the creation of published author, William Nowers. Captain Nowers and his wife, Millie, ... spent thirty years in the Navy. Following his career as a naval aviator ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
Breaking Medicine News(10 mins):